|
National Stock Number(NSN): 6505-01-691-4533 (6505016914533, 016914533)
| NIIN: |
01-691-4533 |
Item Name: |
ADALIMUMAB INJECTION |
INC: |
68439
|
| FSC: |
6505
|
Assignment Date: |
Oct-09-2020 |
CRIT: |
X |
IIG: |
68439 |
| ISC: |
5 |
Date Standardized: |
Oct-09-2020 |
HMIC: |
P |
DODIC: |
|
| NSC: |
0 |
Cancellation Date: |
|
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9225 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
4 |
Originator: |
97 |
ADPEC: |
0 |
RPDMRC: |
3 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
1582722 |
89875
|
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
C |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
6505NCM206473 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
C |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
HUMIRA |
6XMS3
|
ABBVIE US LLC |
C |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00074-4339-02 |
6XMS3
|
ABBVIE US LLC |
C |
3 |
2 |
4 |
ZZ |
|
K |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
L |
|
M |
U |
1 |
A |
$9,351.24 |
EA |
|
C2201X- |
Oct-01-2025 |
C |
| DF |
SMS |
L |
|
M |
U |
1 |
F |
$9,351.24 |
EA |
|
------- |
Oct-01-2025 |
C |
| DM |
SMS |
L |
Z |
M |
U |
1 |
M |
$9,351.24 |
EA |
|
1-54--- |
Oct-01-2025 |
C |
| DN |
SMS |
L |
|
M |
U |
1 |
N |
$9,351.24 |
EA |
|
9B----- |
Oct-01-2025 |
C |
| DS |
SMS |
L |
|
M |
U |
1 |
D |
$11,251.12 |
EA |
|
------- |
Oct-01-2022 |
H |
| DS |
SMS |
L |
|
M |
U |
1 |
I |
$9,351.24 |
EA |
|
------- |
Oct-01-2025 |
C |
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
ADALIMUMAB INJECTION, 40 MG/0.8 ML |
| FEAT |
SPECIAL FEATURES |
HUMIRA IS A TISSUE NECROSIS FACTOR (TNF) BLOCKER INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS TO REDUCE THE SIGNS AND SYMPTOMS INDUCING MAJOR CLINICAL RESPONSE, INHIBITING THE PROGRESSION OF STRUCTURAL DAMAGE, AND IMPROVING PHYSICAL FUNCTION IN ADULT PATIENTS; HUMIRA IS SUPPLIED IN A CARTON CONTAINING A 1 ML PREFILLED GLASS SYRINGE WITH A FIXED 1/2 INCH NEEDLE, PROVIDING 40 MG/0.8 ML OF HUMIRA; THE NEEDLE COVER MAY CONTAIN NATURAL RUBBER LATEX; INTENDED FOR SUBCUTANEOUS ADMINISTRATION; DO NOT USE BEYOND THE EXPIRATION DATE ON THE CONTAINER; HUMIRA MUST BE REFRIGERATED AT 36 F TO 46 F (2 C TO 8 C); DO NOT FREEZE; DO NOT USE IF FROZEN EVEN IF IT HAS BEEN THAWED. |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A911 |
|
Oct-01-2020 |
3 |
Z |
|
|
AM|GX |
AM|BN|GX |
| N9BL |
|
Oct-01-2020 |
3 |
Z |
|
|
GX |
GH|GX |
| MC55 |
|
Oct-01-2020 |
3 |
Z |
|
|
GX|PA |
GX|PA |
| FSGM |
|
Oct-01-2020 |
3 |
Z |
|
|
GX|TT |
GX|SS|TT |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
GX |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
142 |
| Type of Cargo Code: |
Q |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MU |
Air Dimension Code: |
A |
| Source: |
P |
Primary Inventory Control Activity (PICA) |
Status: |
C |
| Pri/Sec ICC: |
P |
Container NSN: |
|
Category Code: |
60Z0 |
| Lvl A Pkg Req: |
Z |
Unit Pack Size: |
|
Pres Material: |
ZZ |
| Lvl B Pkg Req: |
Z |
Unit Pack Weight: |
0.0 |
Pres Method: |
ZZ |
| Lvl C Pkg Req: |
|
Unit Pack Cube: |
0.000 |
Wrapping Mat: |
ZZ |
| Opt Proc Ind: |
M |
Unpkg Item Dims: |
|
Spec Marking: |
ZZ |
| Container FSC: |
|
SPI Number: |
|
SPI Revision: |
|
| Unpkg Weight: |
|
SPI Date: |
|
Pkg Design Activity: |
13873
|
| Inter Container Qty: |
ZZZ |
Inter Container Code: |
ZZ |
Clean/Dry Procedure: |
Z |
| Unit Container: |
ZZ |
Item Type Storage: |
T |
Unit Container Level: |
|
| |
|
Cush/Dun Material: |
ZZ |
Cush/Dun Thickness: |
Z |
|